The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy

2017 ◽  
Vol 76 ◽  
pp. 167-182 ◽  
Author(s):  
Lieve Brochez ◽  
Ines Chevolet ◽  
Vibeke Kruse
Keyword(s):  
Cancer Therapy ◽  
Indoleamine 2,3 Dioxygenase

Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective

2020 ◽  
Vol 63 (24) ◽  
pp. 15115-15139
Author(s):  
Xi Feng ◽  
Dongdong Liao ◽  
Dongyu Liu ◽  
An Ping ◽  
Zhiyu Li ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Indoleamine 2,3 Dioxygenase

Electric Pulse Responsive Magnetic Nanoclusters Loaded with Indoleamine 2,3-Dioxygenase Inhibitor for Synergistic Immuno-Ablation Cancer Therapy

2020 ◽  
Vol 12 (49) ◽  
pp. 54415-54425
Author(s):  
Bo Yu ◽  
Wentao Zhang ◽  
Kijung Kwak ◽  
Hyunjun Choi ◽  
Dong-Hyun Kim
Keyword(s):  
Cancer Therapy ◽  
Electric Pulse ◽  
Magnetic Nanoclusters ◽  
Indoleamine 2,3 Dioxygenase

Abstract 491: NLG919, a novel indoleamine-2,3-dioxygenase (IDO)-pathway inhibitor drug candidate for cancer therapy.

2013 ◽  
Author(s):  
Mario R. Mautino ◽  
Firoz A. Jaipuri ◽  
Jesse Waldo ◽  
Sanjeev Kumar ◽  
James Adams ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Drug Candidate ◽  
Indoleamine 2,3 Dioxygenase ◽  
Inhibitor Drug

101 Combinatorial cancer therapy using a pharmacological inhibitor of indoleamine 2,3-dioxygenase (IDO), a target of the cancer suppression gene Bin1

2004 ◽  
Vol 2 (8) ◽  
pp. 33
Author(s):  
A.J. Muller ◽  
J.B. DuHadaway ◽  
E. Sutanto-Ward ◽  
P.S. Donover ◽  
G.C. Prendergast
Keyword(s):  
Cancer Therapy ◽  
Pharmacological Inhibitor ◽  
Indoleamine 2,3 Dioxygenase ◽  
Cancer Suppression

scholarly journals Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy

2011 ◽  
Vol 40 (4) ◽  
pp. 929-934 ◽  
Author(s):  
DONGDONG WANG ◽  
YASUSHI SAGA ◽  
HIROAKI MIZUKAMI ◽  
NAOTO SATO ◽  
HIROAKI NONAKA ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Therapy ◽  
Natural Killer Cell ◽  
Natural Killer ◽  
Cell Function ◽  
Killer Cell ◽  
Natural Killer Cell Function ◽  
Indoleamine 2,3 Dioxygenase

A Novel Cancer Therapy by Skin Delivery of Indoleamine 2,3-Dioxygenase siRNA

2009 ◽  
Vol 15 (2) ◽  
pp. 641-649 ◽  
Author(s):  
M.-C. Yen ◽  
C.-C. Lin ◽  
Y.-L. Chen ◽  
S.-S. Huang ◽  
H.-J. Yang ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Indoleamine 2,3 Dioxygenase ◽  
Skin Delivery

Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy

2009 ◽  
Vol 9 (8) ◽  
pp. 938-952 ◽  
Author(s):  
X. Liu ◽  
R. Newton ◽  
S. Friedman ◽  
P. Scherle
Keyword(s):  
Cancer Therapy ◽  
Indoleamine 2,3 Dioxygenase ◽  
Anti Cancer

Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?

2009 ◽  
Vol 9 (6) ◽  
pp. 445-452 ◽  
Author(s):  
Stefan Löb ◽  
Alfred Königsrainer ◽  
Hans-Georg Rammensee ◽  
Gerhard Opelz ◽  
Peter Terness
Keyword(s):  
Cancer Therapy ◽  
Indoleamine 2,3 Dioxygenase

Multifunctional metal–organic framework heterostructures for enhanced cancer therapy

2021 ◽  
Author(s):  
Jintong Liu ◽  
Jing Huang ◽  
Lei Zhang ◽  
Jianping Lei
Keyword(s):  
Cancer Therapy ◽  
General Principle ◽  
Biomedical Applications ◽  
Metal Organic Framework ◽  
Metal Organic ◽  
Functional Modulation ◽  
Organic Framework

We review the general principle of the design and functional modulation of nanoscaled MOF heterostructures, and biomedical applications in enhanced therapy.

Sign in / Sign up

Export Citation Format

Share Document